News & Events
In the lab with Dr María José Ulloa Navas
Step into the lab and meet Dr María José Ulloa Navas, a talented MS researcher from Ecuador.…
Margarita Ruiz: a driving force for MS rights in Cuba
The global MS movement remembers Margarita Ruiz, founder and honorary president of MS Cuba.
Prevalence and severity of MS across the world – can new research explain the patterns?
Studies provide insight into the links between MS prevalence, severity, latitude and healthcare spending
Cykelnerven 2022
In June 18 MSIF cyclists took on Europe’s most challenging charity cycling event - Cykelnerven.
Genes unzipped: what our DNA can tell us about MS risk
How do genes affect the risk of developing MS?
Enhancing global collaboration for earlier detection and prevention of MS
Research priorities identified to help better understand the MS prodrome
Solving the mystery of progression: the key to new treatments for progressive MS
Catch up with the latest webcast on unraveling the mystery of progression and identifying new targets for…
10-year Intersectoral global plan approved to improve care for people affected by neurological conditions
MSIF supports the adoption of the WHO's intersectoral global action plan on epilepsy and other neurological disorders,…
Global webcast on ending progressive MS
Learn about important, new research initiatives that will fuel the development of breakthrough treatments for progressive MS.…
How do we improve MS research and care? Let’s act on what people affected by MS are telling us
The global PROMS initiative publishes its plans for realising the full potential of patient reported outcomes for…
An update from the MS Global Data Sharing Initiative – Thank You!
When we come together, we can find answers, quickly, to global MS challenges.
Results of the MS research priority survey for Cochrane systematic reviews
The research questions identified as priority topics by over 1000 people affected by MS and healthcare professionals